Appili Therapeutics Inc.
APLIF
$0.01
$0.0026.39%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 83.00K | 18.20K | 82.50K | 75.50K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.00K | 18.20K | 82.50K | 75.50K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 83.00K | 18.20K | 82.50K | 75.50K | -- |
| SG&A Expenses | 723.50K | 715.00K | 184.30K | 413.70K | 464.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.22M | 2.10M | 597.00K | 1.02M | 1.16M |
| Operating Income | -1.14M | -2.08M | -514.50K | -942.90K | -1.16M |
| Income Before Tax | -1.19M | -724.90K | -674.00K | -692.70K | -880.90K |
| Income Tax Expenses | 5.00K | 29.50K | 7.00K | 25.40K | 22.30K |
| Earnings from Continuing Operations | -1.20M | -754.40K | -681.10K | -718.10K | -903.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.20M | -754.40K | -681.10K | -718.10K | -903.20K |
| EBIT | -1.14M | -2.08M | -514.50K | -942.90K | -1.16M |
| EBITDA | -1.14M | -2.08M | -512.90K | -940.50K | -1.16M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 132.37M | 109.78M | 128.37M | 121.27M | 121.27M |
| Average Diluted Shares Outstanding | 132.37M | 109.78M | 128.37M | 121.27M | 121.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |